Stocks
GlaxoSmithKline (GSK) Net debt US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| Net debt, £ | 19 838 000 000 | 13 110 000 000 | 13 110 000 000 | 12 836 000 000 | 12 836 000 000 | 13 677 000 000 | |||
| Changes by years, y/y, % | 0% | -34% | 0% | -2% | 0% | -10.3% | |||
GlaxoSmithKline. Net debt, £
GlaxoSmithKline. Net debt, changes, %
GlaxoSmithKline (GSK) Net debt US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| Net debt, £ | 14 970 000 000 | 14 153 000 000 | 12 836 000 000 | 12 836 000 000 | 13 677 000 000 | 13 677 000 000 | ||
| Changes by years, y/y, % | -4% | -5% | -2% | -2% | -2% | |||
| Changes by quarters, q/q, % | 0% | -5% | -9% | 0% | +7% | |||
